NovoCure announced today that it presented the results from a single-arm pilot trial evaluating the Novo-TTF, a non-invasive portable medical device, combined with neo-adjuvant chemotherapy for the treatment of patients with locally advanced breast cancer. Tumor volume shrank by 86-100 percent in the first four patients treated with the combined therapy, and one patient has experienced a complete response.

Texas Instruments Incorporated introduced today the industry's lowest input voltage DC/DC boost converter, which will enable portable electronic end-equipment to draw power from new energy sources, such as solar and micro-fuel cells.